1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2024Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01) ANNALS OF ONCOLOGY
2024Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial NATURE MEDICINE
2024The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney diseaseDIABETOLOGIA
2024Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma BRITISH JOURNAL OF CANCER
2024Machine learning-based model to predict delirium in patients with advanced cancer treated with palliative care: a multicenter, patient-based registry cohort SCIENTIFIC REPORTS
2024Opioid use and subsequent delirium risk in patients with advanced cancer in palliative care: a multicenter registry study SCIENTIFIC REPORTS
2024Obstructive sleep apnea and non-dipper: epiphenomena or risks of Alzheimer's disease?: a review from the HOPE Asia NetworkHYPERTENSION RESEARCH
2024Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogsKAOHSIUNG JOURNAL OF MEDICAL SCIENCES
2024Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeksALIMENTARY PHARMACOLOGY & THERAPEUTICS
2024Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysisJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2024Transcriptome-wide analysis reveals GYG2 as a mitochondria-related aging biomarker in human subcutaneous adipose tissue AGING CELL
2024Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY BREAST CANCER RESEARCH AND TREATMENT
2024Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96HIV MEDICINE
2024A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension studyDIABETES OBESITY & METABOLISM
2024Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational studyJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2024Quantitative Coronary Angiography vs Intravascular Ultrasonography to Guide Drug-Eluting Stent Implantation A Randomized Clinical TrialJAMA CARDIOLOGY
2024Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South KoreaAMERICAN JOURNAL OF CARDIOVASCULAR DRUGS
2024Real-world outcome of crizotinib for anaplastic lymphoma kinase-positive lung cancer: Multicenter retrospective analysis in South Korea THORACIC CANCER
2024Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors FUTURE ONCOLOGY
2024Incremental health care expenditures associated with hypertension in South KoreaJOURNAL OF HUMAN HYPERTENSION

Recent Submissions

Browse

Links